02536oam 22005414a 450 991069645760332120230905163625.0(CKB)5470000002378265(OCoLC)57682710(EXLCZ)99547000000237826520030204d2002 ua 0engurcn|||||||||txtrdacontentcrdamediacrrdacarrierPrescription drug therapies[electronic resource] reducing costs and improving outcomes /authors, Barbara L. Kass-Bartlemes, Lynn BoscoRockville, Md. :Agency for Healthcare Research and Quality,[2002]11 pages digital, PDF fileResearch in action ;issue #8AHRQ pub. ;no. 02-0045Title from PDF caption (viewed Mar. 6, 2008)."September 2002."Includes bibliographical references.The report describes Agency for Healthcare Research and Quality (AHRQ) funded research that helps to answer questions about prescription medicine. AHRQ research has identified conditions for which drug therapy is not necessary. It has discovered low-cost drug therapies that provide patients with the same quality of care as more expensive drugs. It has also revealed that sometimes the newest, most expensive drug therapy reduces costs overall because it keeps patients healthier and less likely to use other health care services. AHRQ has also finded research thatb investigated the cost effectiveness and safety of outpatient vs. inpatient services and the impact of preventive drug therapy.Prescription drug therapiesPrescription pricingUnited StatesCostsChemotherapyEconomic aspectsUnited StatesPrescription DrugseconomicsDrug TherapyeconomicsDrug TherapymethodsUnited StatesPrescription pricingCosts.ChemotherapyEconomic aspectsPrescription Drugseconomics.Drug Therapyeconomics.Drug Therapymethods.Kass-Bartelmes Barbara L1388061Bosco Lynn1420956United States.Agency for Healthcare Research and Quality.NLMNLMOCLCQGPOBOOK9910696457603321Prescription drug therapies3540584UNINA